Arkolith/Insider Trading/INMB/Form 4

Lowdell Mark William

Chief Scientific OfficerInmune Bio, Inc. (INMB) · full profile →Form 4 · filed Nov 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 18, 2025Grant(A)104K——104K
Nov 18, 2025Disposed to issuer(D)400K——0
Nov 18, 2025Grant(A)400K——400K
Nov 18, 2025Grant(A)100K——100K
Nov 18, 2025Disposed to issuer(D)100K——0
Nov 18, 2025Grant(A)140K——140K
Nov 18, 2025Disposed to issuer(D)140K——0
Nov 18, 2025Disposed to issuer(D)104K——0
Nov 18, 2025Grant(A)180K——180K
Nov 18, 2025Disposed to issuer(D)180K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-112236) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML